A new intelligence report Transcriptomics Market has been recently added to The Brainy Insights Market Research collection of top-line market research reports. Global Transcriptomics Market report is a meticulous all-inclusive analysis of the market that offers access to direct first-hand insights on the growth trail of market in near term and long term. On the basis of factual information sourced from authentic industry experts and extensive primary industry research, the report offers insights on the historic growth pattern of Transcriptomics Market and current market scenario. It then provides shortand long-term market growth projections. The global transcriptomics market was valued at USD 6.6 billion in 2022 and is anticipated to grow at a CAGR of 7.6 % from 2022 to 2030, The global transcriptomics market is expected to reach USD 11.85 billion by 2030. Get Access to PDF Sample of Transcriptomics Market Status and Trend Analysis 2023-2032 (COVID-19 Version) @ https://www.thebrainyinsights.com/enquiry/sample-request/12959
Projections are purely based on the detailed analysis of key market dynamics that are expected to influence Transcriptomics Market performance and their intensity of impacting market growth over the course of assessment period. In addition to evaluation of dynamics, the report provides in-depth examination of key industry trends that are expected to act more prominently in global Transcriptomics Market. The study also offers valued information about the existing and upcoming growth opportunities in Transcriptomics Market that the key players and new market entrants can capitalize on. Highlighted of Global Transcriptomics Market Segments and Sub-Segment: Transcriptomics Market by Key Players: Pacific Biosciences of California Inc., Thermo Fisher Scientific Inc., Agilent Technologies Inc., Illumina Inc., QIAGEN, Bio-Rad Laboratories Inc., Takara Bio Inc., PerkinElmer Inc., Fluidigm Corporation, 10X Genomics, NanoString, Becton, Dickinson and Company (B.D.), Bio-Techne, Cytiva, BioSypder Inc., ANGLE plc, Menarini Silicon Biosystems